| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2007 | WO2007063071A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors |
| 06/07/2007 | WO2007063043A1 Improved anti-microbial composition |
| 06/07/2007 | WO2007063042A1 R-mirtazapine for the treatment of pain |
| 06/07/2007 | WO2007063013A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 06/07/2007 | WO2007063012A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 06/07/2007 | WO2007063010A1 Novel vinylogous acids derivatives |
| 06/07/2007 | WO2007063009A1 Serotonin transporter (sert) inhibitors |
| 06/07/2007 | WO2007063000A1 5-substituted indole-2-carboxamide derivatives |
| 06/07/2007 | WO2007062998A1 3-amino-2-arylpropyl azaindoles and uses thereof |
| 06/07/2007 | WO2007062997A1 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 06/07/2007 | WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | WO2007062957A1 Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching |
| 06/07/2007 | WO2007062876A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 06/07/2007 | WO2007062875A1 Heteroaromatic sulfonamide prodrugs |
| 06/07/2007 | WO2007062874A2 Sulfamoyl sulfonate prodrugs |
| 06/07/2007 | WO2007062862A2 Use of calmodulin inhibitors for the treatment of neurodegenerative disorders |
| 06/07/2007 | WO2007062837A2 Use of a 5-ht4 agonist for the treatment of irritable bowel syndrome characterized by mixed or alternating bowel habits |
| 06/07/2007 | WO2007062817A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position |
| 06/07/2007 | WO2007062815A1 Neramexane modified release matrix tablet |
| 06/07/2007 | WO2007062805A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS |
| 06/07/2007 | WO2007062797A1 Amino-substituted azo-heterocyclic compounds for treating inflammatory conditions |
| 06/07/2007 | WO2007062773A1 Oxadiazole derivatives with crth2 receptor activity |
| 06/07/2007 | WO2007062678A1 Phenoxyacetic acid derivatives as crth2 receptor ligands |
| 06/07/2007 | WO2007062677A1 Thiazolyl- and pyrimidinyl-acetic acids and their use as crth2 receptor ligands |
| 06/07/2007 | WO2007062595A1 Bismuth hyaluronate, the preparation method and the use theirof |
| 06/07/2007 | WO2007062568A1 Compounds used as mammalian cell amp-activated protein kinase(ampk) activators and their preparation methods and usages |
| 06/07/2007 | WO2007062564A1 Lyophilized taxane-liposome composition and its preparing process |
| 06/07/2007 | WO2007062546A1 Iron-saccharide complexs easy to reconstitute and the method for manufacture them |
| 06/07/2007 | WO2007062542A2 Process for the manufacture of epoxybutanol intermediates |
| 06/07/2007 | WO2007062531A1 Combination treatments with gastrin agonists for diabetes and related diseases |
| 06/07/2007 | WO2007062528A1 Polycyclic phenolic compounds and use in treating viral infections |
| 06/07/2007 | WO2007062483A1 Increasing pregnancy rates |
| 06/07/2007 | WO2007062474A1 An expression system construct comprising ires and uses thereof |
| 06/07/2007 | WO2007062468A1 Biologically active compounds |
| 06/07/2007 | WO2007062462A1 Method for administering a skin necrosis composition to an animal |
| 06/07/2007 | WO2007062459A1 Selective kinase inhibitors based on pyridine scaffold |
| 06/07/2007 | WO2007057742A3 Novel piperazinone derivatives |
| 06/07/2007 | WO2007048353B1 Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 06/07/2007 | WO2007048088A3 Method of inhibiting flt3 kinase |
| 06/07/2007 | WO2007048027A3 Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| 06/07/2007 | WO2007047431A3 Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors |
| 06/07/2007 | WO2007046721A3 A method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and an anti-aging composition |
| 06/07/2007 | WO2007045551A3 Renin inhibitors nitroderivatives |
| 06/07/2007 | WO2007045353A3 Combined preparation of o-acetylsalicylic acid salts |
| 06/07/2007 | WO2007044565A3 Composition and synthesis of new reagents for inhibition of hiv replication |
| 06/07/2007 | WO2007044426A3 Pyrazolopyrimidines as protein kinase inhibitors |
| 06/07/2007 | WO2007044401A3 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007043710A9 Novel dihydropseudoerythromycin derivatives |
| 06/07/2007 | WO2007043702A9 Agent for applying to mucosa and method for production thereof |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007043542A9 Antituberculous composition comprising oxazole compounds |
| 06/07/2007 | WO2007042786A3 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 06/07/2007 | WO2007042048A3 Method for preparing crystalline sodium risedronate |
| 06/07/2007 | WO2007041440A3 Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
| 06/07/2007 | WO2007041076A3 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 06/07/2007 | WO2007038860A3 Odcase inhibitors as anti-virals and antibiotics |
| 06/07/2007 | WO2007038676A3 Polymorphic forms of ladostigil tartrate |
| 06/07/2007 | WO2007038073A3 Mutations and polymorphisms of hdac11 |
| 06/07/2007 | WO2007037898A3 Theramutein modulators |
| 06/07/2007 | WO2007033110A3 Liposomes for treatment of multiple myeloma |
| 06/07/2007 | WO2007032010A3 Use of tellurium compounds for protection from ultra-violet radiation |
| 06/07/2007 | WO2007031977A3 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 06/07/2007 | WO2007031968A3 Porous coating loaded with a liquid or a solid substance |
| 06/07/2007 | WO2007031867A3 A hepatitis c virus non-stru tural ns3/4a fusion gene |
| 06/07/2007 | WO2007031326A3 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 06/07/2007 | WO2007030940A3 Methods of modulating neurotrophin-mediated activity |
| 06/07/2007 | WO2007028812A3 Selected cgrp antagonists method for production and use thereof as medicament |
| 06/07/2007 | WO2007028132A3 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 06/07/2007 | WO2007028104A3 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 06/07/2007 | WO2007025090A3 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| 06/07/2007 | WO2007024949A3 Alpha2c adrenoreceptor agonists |
| 06/07/2007 | WO2007024768A3 Pheromone compositions and methods |
| 06/07/2007 | WO2007024744A3 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands |
| 06/07/2007 | WO2007024472A3 USE OF PAR- l/PAR- 4 INHIBITORS FOR TREATING OR PREVENTING VASCULAR DISEASES |
| 06/07/2007 | WO2007022509A3 Use of seh inhibitors as analgesics |
| 06/07/2007 | WO2007020204A3 Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate |
| 06/07/2007 | WO2007020103A3 Novel use of peptide compounds for treating muscle pain |
| 06/07/2007 | WO2007017875A3 Drug delivery system for topical administration |
| 06/07/2007 | WO2007016656A3 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/07/2007 | WO2007016495A3 Fluorescent sensors for cellular amines |
| 06/07/2007 | WO2007015931A3 Caspase inhibitor prodrugs |
| 06/07/2007 | WO2007015877A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| 06/07/2007 | WO2007015870A3 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 06/07/2007 | WO2007015837A3 Inhibitors of checkpoint kinases |
| 06/07/2007 | WO2007014155A3 Method for treating sickle cell disease and sickle cell disease sequelae |
| 06/07/2007 | WO2007011232A3 Lipid lowering agents for increasing bmd |
| 06/07/2007 | WO2007010369B1 Sustained release formulation of alprazolam |
| 06/07/2007 | WO2007010281A3 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 06/07/2007 | WO2007009703A3 New formulations of substituted pyrazoline compounds |
| 06/07/2007 | WO2007009109A3 Antiviral compounds |
| 06/07/2007 | WO2007002258A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 06/07/2007 | WO2007000771A3 Fused quinazolinone derivatives and uses thereof |
| 06/07/2007 | WO2006138350A3 Chemokine receptor binding compounds |
| 06/07/2007 | WO2006138048A3 Formulations comprising fluphenazine or derivatives thereof |
| 06/07/2007 | WO2006137106A3 Method for the potentiation of opioid analgesics effects on pain |
| 06/07/2007 | WO2006133194A3 Methods for treating viral infection with oral or injectible drug solution |
| 06/07/2007 | WO2006127907A3 Localized delivery of cardiac inotropic agents |
| 06/07/2007 | WO2006127591A3 Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/07/2007 | WO2006127287A3 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods |